Cargando…

Repeated measurements of N-terminal pro-brain natriuretic peptide enable dynamic risk stratification in critically ill patients

Detalles Bibliográficos
Autores principales:	Meyer, B, Hülsmann, M, Wexberg, P, Nikfardjam, M, Strunk, G, Szekeres, T, Gouya, G, Pacher, R, Heinz, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084259/ http://dx.doi.org/10.1186/cc7537

Ejemplares similares

CT-pro-endothelin-1 and prognosis in critically ill patients with respiratory failure
por: Meyer, B, et al.
Publicado: (2009)

Pro-B-type natriuretic peptide predicts mortality in critically ill patients
por: Meyer, B, et al.
Publicado: (2005)

Mid-regional pro-atrial natriuretic peptide is a strong predictor of outcome in an unselected cohort of critically ill patients
por: Meyer, B, et al.
Publicado: (2007)

Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide
por: Liu, Pang-Yen, et al.
Publicado: (2023)

Copeptin is a strong and independent predictor of outcome in cardiogenic shock
por: Meyer, B, et al.
Publicado: (2009)

Predictive value of N-terminal pro-brain natriuretic peptide among critically ill patients
por: Cubrilo-Turek, M, et al.
Publicado: (2012)

N-Terminal Pro-B-Type Natriuretic Peptide in Risk Stratification of Heart Failure Patients With Implantable Cardioverter-Defibrillator
por: Deng, Yu, et al.
Publicado: (2022)

Copeptin and acute renal failure in critically ill patients
por: Meyer, B, et al.
Publicado: (2008)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Copeptin as a marker of shock and predictor of adverse outcome in critically ill patients
por: Meyer, B, et al.
Publicado: (2008)

Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients
por: Koch, Alexander, et al.
Publicado: (2011)

N‐Terminal Pro Brain, N‐Terminal Pro Atrial Natriuretic Peptides, and Dynamic Cerebral Autoregulation
por: Mahinrad, Simin, et al.
Publicado: (2020)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

N‐Terminal Pro‐C‐Natriuretic Peptide and Cytokine Kinetics in Dogs with Endotoxemia
por: Floras, A.N.K., et al.
Publicado: (2014)

The Use of N-Terminal Pro-Brain Natriuretic Peptide to Evaluate Vascular Disease in Elderly Patients with Mental Illness
por: Nilsson, Karin, et al.
Publicado: (2012)

NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
por: Lazo, Mariana, et al.
Publicado: (2013)

N-terminal pro brain natriuretic peptide in coronary artery disease
por: Tin, Sim Sai, et al.
Publicado: (2015)

N-Terminal Pro–B-Type Natriuretic Peptide and Incident CKD
por: Sasaki, Takaya, et al.
Publicado: (2021)

Comparison of Transthoracic Echocardiography With N-Terminal Pro-Brain Natriuretic Peptide as a Tool for Risk Stratification of Patients Undergoing Major Noncardiac Surgery
por: Park, Sung-Ji, et al.
Publicado: (2011)

Relationship of diabetes, heart failure, and N‐terminal pro‐B‐type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation
por: Hofer, Felix, et al.
Publicado: (2022)

The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology
por: Kimmenade, Van, et al.
Publicado: (2007)

Reply to: N-terminal pro brain natriuretic peptide in coronary artery disease
por: Radwan, Hanan, et al.
Publicado: (2015)

Levels of N-terminal pro-brain natriuretic peptide in brain injury patients
por: Tsentsiper, L, et al.
Publicado: (2015)

N-terminal Pro-B-Type Natriuretic Peptide and Malnutrition in Patients on Hemodialysis
por: Ducros, Jacques, et al.
Publicado: (2020)

Diastolic but not systolic dysfunction is associated with troponin and N-terminal pro-brain natriuretic peptide elevation in sepsis
por: Landesberg, G, et al.
Publicado: (2009)

Performance of N-terminal-pro-B-type natriuretic peptide in critically ill patients: a prospective observational cohort study
por: Coquet, Isaline, et al.
Publicado: (2008)

Critical illness polyneuropathy: incidence and risk factors
por: Meyer, B, et al.
Publicado: (2006)

Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP)
por: Maries, Lorena, et al.
Publicado: (2013)

Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure
por: Shao, Mingliang, et al.
Publicado: (2015)

Clinical correlation between N-terminal pro-b-type natriuretic peptide and angiographic coronary atherosclerosis
por: Ribeiro, Demóstenes G. L., et al.
Publicado: (2014)

Urinary N‐terminal pro‐brain natriuretic peptide: prognostic value in patients with acute chest pain
por: Reynen, Stefanie, et al.
Publicado: (2021)

N-Terminal Pro-B-type Natriuretic Peptide Levels in the Korean General Population
por: Lee, Kyung-Hoon, et al.
Publicado: (2010)

Prognostic value of amino terminal pro-b-type natriuretic peptide in septic patients
por: Maroto, Fernando, et al.
Publicado: (2008)

Amino-terminal pro-brain natriuretic peptide in children with latent rheumatic heart disease
por: Zachariah, Justin P, et al.
Publicado: (2016)

Midregional pro-Adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study
por: Potocki, Mihael, et al.
Publicado: (2009)

Prognostic value of pro-atrial natriuretic peptide, pro-adrenomedullin, and pro-endothelin-1 in critically ill patients
por: Bloos, F, et al.
Publicado: (2006)

Determination and stability of N-terminal pro-brain natriuretic peptide in saliva samples for monitoring heart failure
por: Bellagambi, Francesca G., et al.
Publicado: (2021)

Repeated Measurements of Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Assess Long-Term Mortality Risk in Subjects with Osteoarthritis
por: Rehm, Martin, et al.
Publicado: (2021)

The Association of Mid-Regional Pro-Adrenomedullin and Mid-Regional Pro-Atrial Natriuretic Peptide with Mortality in an Incident Dialysis Cohort
por: Gouya, Ghazaleh, et al.
Publicado: (2011)

Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction
por: Cui, Kun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_44hi73mmq6e57ln3qhgf23n9rg